Literature DB >> 6803512

Localization of factor VIII/von Willebrand factor and glial fibrillary acidic protein in the hemangioblastoma: implications for stromal cell histogenesis.

R D McComb, T R Jones, S V Pizzo, D D Bigner.   

Abstract

The histogenesis of hemangioblastoma stromal cells is unresolved. Ultrastructural observations suggest that the stromal cells, endothelial cells, and pericytes that compose this neoplasm are all derived from angiogenic mesenchyme. The expression of factor VIII/von Willebrand factor (FVIII/vWF), a specific marker for endothelial cells, and of glial fibrillary acidic protein (GFAP), a specific marker for glial cells, was examined in 16 hemangioblastomas using the peroxidase-antiperoxidase immunohistochemical method. Endothelial cell staining for FVIII/vWF was intense in 14 tumors, weak in one, and absent in another. There was no stromal cell staining in any of the neoplasms. Process-bearing, GFAP-positive cells were observed near the tumor margin in 13 cases, and deeper in the neoplasm in 8. In two of these tumors there were also occasional GFAP-positive cells that lacked processes and had a vacuolated cytoplasm. Virtually all of the GFAP-positive cells were interpreted as trapped astrocytes rather than stromal cells. The lack of expression of FVIII/vWF by the stromal cells indicates that they are antigenically distinct from endothelial cells. Several alternatives for stromal cell histogenesis remain open. The stromal undergone antigenic loss, or from angiogenic mesenchymal cells that do not express FVIII/vWF. Alternatively, the stromal cells may originate from non-angiogenic mesenchymal cells derived from the mesoderm or neuroectoderm.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6803512     DOI: 10.1007/BF00690637

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  39 in total

1.  Cerebellar hemangioma (hemangioblastoma); a clinicopathological review of 40 cases.

Authors:  M L SILVER; G HENNIGAR
Journal:  J Neurosurg       Date:  1952-09       Impact factor: 5.115

2.  Haemangioxanthoma of the brain; a study of eight cases of socalled pseudo-xanthomatous haemangioblastoma.

Authors:  V J McGOVERN; B D WYKE
Journal:  Med J Aust       Date:  1948-03-06       Impact factor: 7.738

3.  DISCUSSION ON VASCULAR TUMOURS OF THE BRAIN AND SPINAL CORD: Joint Discussion No. 1.

Authors: 
Journal:  Proc R Soc Med       Date:  1931-01

4.  Alpha 1-antitrypsin in human macrophages.

Authors:  P Isaacson; D B Jones; M A Judd
Journal:  Lancet       Date:  1979-11-03       Impact factor: 79.321

Review 5.  The migration and differentiation of neural crest cells.

Authors:  J A Weston
Journal:  Adv Morphog       Date:  1970

6.  Extramedullary hemangioblastoma of the spinal cord. Case report.

Authors:  H S Wisoff; Y Suzuki; J F Llena; D I Fine
Journal:  J Neurosurg       Date:  1978-03       Impact factor: 5.115

7.  Blood group isoantigens in angioblastic meningiomas and hemangioblastomas of the central nervous system.

Authors:  K Jellinger; H Denk
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1974

8.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

9.  Extracellular matrix proteins characterize human tumor cell lines.

Authors:  K Alitalo; J Keski-Oja; A Vaheri
Journal:  Int J Cancer       Date:  1981-06-15       Impact factor: 7.396

10.  Glial fibrillary acidic protein in stromal cells of some capillary hemangioblastomas: significance and possible implications of an immunoperoxidase study.

Authors:  J H Deck; L J Rubinstein
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

View more
  9 in total

1.  Histogenesis of stromal cells in cerebellar hemangioblastomas. An immunohistochemical study.

Authors:  I Becker; W Paulus; W Roggendorf
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

2.  Capillary hemangioblastoma: histogenesis of stromal cells.

Authors:  H Kamitani; H Masuzawa; J Sato; I Kanazawa
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

3.  Immunohistochemical demonstration of vimentin in human cerebral tumors.

Authors:  D Schiffer; M T Giordana; A Mauro; A Migheli; I Germano; G Giaccone
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

4.  Distribution of collagen type IV in brain tumors: an immunohistochemical study.

Authors:  K Ogawa; M Oguchi; Y Nakashima; H Yamabe
Journal:  J Neurooncol       Date:  1989-11       Impact factor: 4.130

5.  Sarcoma arising as a distinct nodule within glioblastoma: a morphological and molecular perspective on gliosarcoma.

Authors:  Cynthia Jimenez; Martin Powers; Andrew T Parsa; Christine Glastonbury; Jill M Hagenkord; Tarik Tihan
Journal:  J Neurooncol       Date:  2011-05-01       Impact factor: 4.130

6.  Selective localization of gamma-enolase in stromal cells of cerebellar hemangioblastomas.

Authors:  J A Feldenzer; P E McKeever
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

7.  Immunohistochemical study of fibronectin in hemangioblastomas and hemangiopericytomas.

Authors:  N Kochi; E Tani; K Kaba; S Natsume
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

8.  Distribution of endothelial and basement membrane markers in angiogenic tumors of the nervous system.

Authors:  T Böhling; A Paetau; P Ekblom; M Haltia
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

9.  Haemangioblastoma. An immunohistochemical study of ten cases.

Authors:  J W Grant; P J Gallagher; C Hedinger
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.